Specifications - Lyrica (Pregabalin) - New Gabapentinoid with Wide Clinical Application

Key Data
Drug (brand/generic)	Lyrica / pregabalin
Company/licensee	Pfizer
Therapy class	Antiepileptic
Product description	GABA analogue
Current indication	Treatment of neuropathic pain, adjunctive therapy in epilepsy and treatment of generalised anxiety disorder
Market sector	CNS, pain control
Development status	Approved for neuropathic pain in both Europe and the US and additionally for partial seizures in Europe